Peptide Therapy Platform: The Complete Selection Guide
A peptide therapy platform is a service that supplies everything a medically supervised peptide program needs: licensed provider coverage, compounding pharmacy fulfillment, patient signup, and compliance. It is for business owners, med spas, gyms, creators, and entrepreneurs who want to launch a peptide program without building clinical infrastructure themselves.
If you are deciding where to launch a peptide program, this guide covers what you are actually buying, the five components that decide success, the math behind building it yourself, and the questions to ask before you sign. The same peptide therapy model that powers direct-to-consumer brands is available to any business owner.
Why Peptide Programs Fail on Broken Stacks
Peptide demand is real and growing. Precedence Research projects the global peptide therapeutics market will grow from USD 52.59 billion in 2025 to USD 87.21 billion by 2035, a 5.19 percent compound annual growth rate. Direct-to-consumer brands capture a growing share of that demand, which is why business owners are evaluating this category: they already have the patients, and they want the revenue the DTC brands are collecting.
The common failure pattern is a stack assembled from five vendors and a dream: separate contracts for signup, provider coverage, a compounding pharmacy, compliance review, and patient messaging, with the business owner acting as the integration layer.
Each vendor does its narrow job well, and the trouble starts at the seams between them. A patient expresses interest on your site and starts the signup. Somewhere between the signup provider and the clinical review, the process stalls. The patient never hears back, assumes the program is broken, and buys from a direct-to-consumer brand instead. When you call the signup provider, they point at the review team, who blames the pharmacy’s API. Nobody owns the patient experience, so the patient is lost.
Every handoff is a place where patients drop off, and a real program has several: interest to signup, signup to screening, screening to provider review, review to prescription, prescription to fulfillment. In a DIY stack, every handoff is a contract boundary between companies that do not answer for each other.
Compliance gaps work the same way. Telehealth prescribing rules change at the federal and state level, and FDA guidance on which peptides can be compounded shifts over time. In a multi-vendor stack, compliance is whoever you paid to watch it, and if nobody was paid, the exposure lands on you.
The costs are quiet. Patients lost at handoffs are acquisition spend with no enrollment behind it, and the owner is pulled into vendor troubleshooting instead of marketing. The revenue math suffers before it ever starts, because every drop-off point is a percentage of the patients you paid to bring in. The launch stalls through a hundred small failures rather than one dramatic one.
The Five Components That Matter
Before you compare platforms, know what has to happen between the moment a patient expresses interest and the moment a prescription ships:
- The patient completes signup and passes a screening.
- A licensed provider reviews the case and issues an approval, rejection, or info request.
- The prescription routes to a licensed compounding pharmacy.
- The medication is compounded and shipped to the patient.
- The program tracks refills and handles renewals with a new provider review.
That is the operation you are buying. A platform either provides each step or leaves it to you. Five components decide whether the launch succeeds, and each one is framed here as what you do not have to build yourself.
Brand and White-Label Control
You own the brand, the pricing, the patients, and the revenue. What you do not build is the technology behind it. The signup experience runs on your site under your name, provider communications carry your brand, and medication arrives under your program’s branding. For a med spa, gym, salon, or creator, this converts existing trust into a new revenue line. For the full model, including what a program includes and how fast it launches, see our guide to white-label peptide telehealth programs.
Provider Coverage
Every prescription must be issued by a licensed provider. You either bring your own or use the platform’s provider network, which covers all 50 states. This is the component that decides whether you need a medical license: you do not, because the providers hold the licenses. If you are a licensed provider yourself, you can review cases under your own authority. The trade-offs between contracting a medical director and drawing on a provider network are covered in our comparison of medical directors vs. provider networks.
Compounding Pharmacy Fulfillment
The prescription routes to a licensed compounding pharmacy that prepares and ships the medication. What you do not build: pharmacy contracts, inventory, shipping logistics, and quality review. What you should still verify: which compounding pharmacies the platform routes to, and whether you can review their licenses. Our guide to choosing a compounding pharmacy partner covers what to check before you trust a program to one.
Compliance
Telehealth prescribing carries federal and state requirements, and FDA guidance on which peptides can be compounded changes over time. A platform carries the compliance foundation: credentialed providers, LegitScript-compliant partners, and a menu limited to what is legal today. That means Category-1 peptides such as Sermorelin and PT-141. Category-2 peptides remain pending FDA reclassification and cannot be legally compounded until the rule is finalized. Our Category-1 peptide guide covers the current list and what it means for your program menu.
Patient Acquisition
This is the one component no platform can supply. The platform provides the mechanism: a conversion-ready signup running on your site. The audience is yours, whether that is a gym’s foot traffic, a med spa’s client list, or a creator’s following. A platform that promises to bring you patients is either misrepresenting the service or charging for something you already do better.
A platform that covers the first four components and leaves you the fifth is a complete business. A platform that leads with EMR features and provider tools is selling to licensed providers, not to business owners, which means you will still assemble the rest of the stack yourself.
DIY vs. Platform: The Cost, Time, and Effort Math
The choice between a DIY vendor stack and an all-in-one peptide therapy platform is a choice about who carries the work. The difference shows up in four costs: time, legal spend, attention, and revenue.
| DIY vendor stack | All-in-one platform | |
|---|---|---|
| Setup time | 60+ days for most platforms (30 in some cases) | Same day |
| Legal work | Entity setup, provider contracts, state-by-state review, ongoing counsel | Included |
| Provider coverage | You recruit, credential, and contract prescribers yourself | Provider network provided, or bring your own |
| Compounding pharmacy | You negotiate and integrate with each pharmacy | Connected and managed for you |
| Compliance | You track FDA guidance and state rules on your own | Handled by the platform |
| Patient ownership | Yours, if the launch survives setup | Yours from day one |
| Ongoing effort | Every vendor renewal, contract dispute, and fix is on you | One platform, one relationship |
Time. A DIY build touches entity formation, provider contracts, pharmacy agreements, and a patient experience assembled from parts. Most turn-key telehealth platforms take 60 days or more to get a program live, and some manage it in 30. Karpa can put a branded program live the same day, with setup taking about 20 minutes once your branding is ready. During that window, your patients keep buying from direct-to-consumer competitors or unregulated online suppliers.
Legal spend. The legal work is where DIY stacks surprise owners. Provider contracts, pharmacy agreements, state telehealth rules, and FDA compliance all need review from someone qualified to give it. That is significant legal spend before you enroll a single patient, with no guarantee the setup survives contact with a regulator. A platform carries the compliance foundation, so the review work is done once, by people who do it full time.
Attention. The quietest cost is your time. A five-vendor stack is a part-time job of renewals, disputes, and integration fixes. The owner who should be marketing the program is instead troubleshooting it. An all-in-one platform replaces that with a flat monthly platform fee plus pass-through costs for the medication and provider consults. You set patient pricing and keep the margin above those costs.
Revenue. Revenue per enrolled patient over the first year outweighs the platform fee on paper. When a program launches in days instead of months, the first months of revenue land in your account instead of being spent on setup.
Red Flags and Evaluation Questions
Most platforms will tell you they handle everything. The check is in how they answer these questions. Walk away over any of these red flags:
- The platform cannot name the compounding pharmacies it routes to, or refuses to let you verify their licenses.
- The platform is vague about provider coverage by state, or answers “we handle it” without specifics.
- The platform does not know which peptides are legally compoundable and which are pending FDA reclassification.
- The pricing is a list of surprises: per-consult fees, per-refill fees, and setup charges that appear only in the contract.
- The contract does not state who owns the patient data and the patient relationship.
- The platform cannot show you the patient experience at each step. The patient experience is what you are actually buying.
Questions to Ask Before You Sign
- Which states does your provider network cover, and what happens if my state changes its telehealth rules?
- Can I bring my own provider, or am I required to use the network?
- Which compounding pharmacies are connected, and can I review their licenses?
- Who owns the patient relationship and the patient data if we part ways?
- What is the complete cost structure, including the monthly platform fee, provider consults, and refills?
- Which peptides can I offer on day one, and how do you keep the menu current with FDA guidance?
- How fast can I go live, and what do I need to provide?
The right platform will answer all of these in writing, and the answers will match the contract.
Making the Decision
Peptide therapy is a fast-growing, high-margin program category, and the platform you choose decides whether you capture it as revenue or as a project that never ships. The buyers who do well pick the model first: bring their own provider coverage or use a network, name the compounding pharmacies, and confirm in writing who owns the patient. Then they go live and start marketing to the audience they already have. If you are coming from a research-use-only peptide business, the first question is not which platform has the longest feature list but which one puts you on a legitimate prescribed path fastest.
Book a call with Karpa Health to walk through the comparison for your business: which programs to launch, what the cost structure looks like at your pricing, and how fast you can be live. For more on the model behind platforms like this, our guide to turnkey peptide telehealth covers how the components fit together.
